- Home
- EXOZ vs ICAD Comparison
EXOZ vs ICAD Comparison
Compare EXOZ & ICAD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EXOZ
- ICAD
- Stock Information
- Founded
- EXOZ 2014
- ICAD 1984
- Country
- EXOZ United States
- ICAD United States
- Employees
- EXOZ N/A
- ICAD N/A
- Industry
- EXOZ
- ICAD Medical/Dental Instruments
- Sector
- EXOZ
- ICAD Health Care
- Exchange
- EXOZ NYSE
- ICAD Nasdaq
- Market Cap
- EXOZ 89.8M
- ICAD 103.3M
- IPO Year
- EXOZ N/A
- ICAD 1986
- Fundamental
- Price
- EXOZ $9.90
- ICAD $3.89
- Analyst Decision
- EXOZ
- ICAD Hold
- Analyst Count
- EXOZ 0
- ICAD 1
- Target Price
- EXOZ N/A
- ICAD N/A
- AVG Volume (30 Days)
- EXOZ 8.7K
- ICAD 247.0K
- Earning Date
- EXOZ 08-15-2025
- ICAD 08-12-2025
- Dividend Yield
- EXOZ N/A
- ICAD N/A
- EPS Growth
- EXOZ N/A
- ICAD N/A
- EPS
- EXOZ N/A
- ICAD N/A
- Revenue
- EXOZ N/A
- ICAD $19,528,000.00
- Revenue This Year
- EXOZ N/A
- ICAD $3.60
- Revenue Next Year
- EXOZ N/A
- ICAD N/A
- P/E Ratio
- EXOZ N/A
- ICAD N/A
- Revenue Growth
- EXOZ N/A
- ICAD 8.86
- 52 Week Low
- EXOZ $8.50
- ICAD $1.18
- 52 Week High
- EXOZ $23.99
- ICAD $4.02
- Technical
- Relative Strength Index (RSI)
- EXOZ N/A
- ICAD 56.95
- Support Level
- EXOZ N/A
- ICAD $3.58
- Resistance Level
- EXOZ N/A
- ICAD $3.88
- Average True Range (ATR)
- EXOZ 0.00
- ICAD 0.13
- MACD
- EXOZ 0.00
- ICAD -0.03
- Stochastic Oscillator
- EXOZ 0.00
- ICAD 66.67
About EXOZ EXOZYMES INC
EXoZymes Inc is focused on using a biomanufacturing platform to create valuable biochemicals, including Active Pharmaceutical Ingredients or APIs, biofuels, food flavors, and cosmetics, offering a sustainable alternative to traditional chemical production methods.
About ICAD iCAD Inc.
icad Inc is a medical technology company providing cancer detection and therapy solutions. The Company operates in one segment: Detection. The Detection segment includes image analysis and workflow solutions that enable healthcare professionals to serve patients by identifying pathologies, comprehensive range of high-performance, Artificial Intelligence and Computer-Aided Detection (CAD) systems and workflow solutions for 2D and 3D mammography, Magnetic Resonance Imaging and Computed Tomography. The company geographically operates in France, Belgium, Italy, Germany, Switzerland and All other.